Michael R. Hayden - Insider Trading & Ownership

Entity
Individual
Location
C/O Aspreva Pharmaceuticals Corporation, 1203 4464 Markham Street, Victoria, British Columbia, Canada
Summary
The estimated net worth of Michael R. Hayden is at least $10.7M dollars as of July 3, 2024. Michael R. Hayden is the Director of AbCellera Biologics Inc. and owns shares of AbCellera Biologics Inc. (ABCL) stock worth about $3.89M. Michael R. Hayden is the Director of Xenon Pharmaceuticals Inc. and owns shares of Xenon Pharmaceuticals Inc. (XENE) stock worth about $3.18M. Michael R. Hayden is the Director of IONIS PHARMACEUTICALS INC and owns shares of IONIS PHARMACEUTICALS INC (IONS) stock worth about $1.98M. Michael R. Hayden is the Director of 89bio, Inc. and owns shares of 89bio, Inc. (ETNB) stock worth about $1.64M.
All Insider Reports
All Insider Reports

Ownership of Michael R. Hayden

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
ABCL AbCellera Biologics Inc. Director $3.89M Jun 21, 2024
XENE Xenon Pharmaceuticals Inc. Director $3.18M Jun 3, 2021
IONS IONIS PHARMACEUTICALS INC Director $1.98M Jul 1, 2024
ETNB 89bio, Inc. Director $1.64M Feb 1, 2024

Insider Transactions Reported by Michael R. Hayden:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.